For the first time, the US Food and Drug Administration has approved the use of a continuous glucose monitoring (CGM) system to replace finger-stick testing for determining insulin doses. The decision ...

Approval for the technology, which integrates with a smartphone, came sooner than company officials expected. A fully mobile continuous glucose monitoring (CGM) system, which features wireless ...

Share price of DexCom, Inc. DXCM jumped 4.8% on Aug 25, following the FDA approval of the DexCom G5 Mobile Continuous Glucose Monitoring (CGM) System. The fully portable product is the first and ...

A new diabetes device may make tracking blood sugars and taking medication easier. The U.S. Food and Drug Administration said Tuesday that the Dexcom G5 continuous glucose monitoring system (CGM) can ...

In the United States, diabetes patients who use the Dexcom G5 Mobile continuous glucose monitoring system have had the convenience of viewing their blood glucose data on their smartphones. Users of ...

SAN DIEGO--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ:DXCM), the leader in continuous glucose monitoring for people with diabetes, announced today the U.S. Centers for Medicare & Medicaid Services (CMS) is ...

DexCom Inc. DXCM recently announced that its G5 PLATINUM Continuous Glucose Monitoring (CGM) System with Share app will be available on Apple’s AAPL Watch. Notably, DexCom CGM and its mobile apps – ...

It’s a pretty good day for San Diego-based Dexcom. The company announced that it won CE Mark approval for its G5 continuous glucose monitor in the European Union. This means the device will be ...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM) the leader in continuous glucose monitoring (CGM) for people with diabetes, is pleased to announce the Food and Drug Administration (FDA) ...

The device includes a small sensor, placed just beneath the skin of my belly, and displays my blood glucose levels right on my Apple Watch. We all know about the market for wearable health trackers, ...

The agreement paves the way for those over age 65 to gain access to continuous glucose monitoring, following a historic policy change. Ascensia Diabetes Care and Dexcom have reached an agreement that ...